The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome. Issue 5 (1st January 2020)
- Record Type:
- Journal Article
- Title:
- The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome. Issue 5 (1st January 2020)
- Main Title:
- The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome
- Authors:
- Jörg, Lukas
Yerly, Daniel
Helbling, Arthur
Pichler, Werner - Abstract:
- Abstract: Background: Multiple drug hypersensitivity syndrome (MDH) is used to describe persons with a drug hypersensitivity reaction (DHR) to at least two chemically unrelated drugs, confirmed by skin test or in vitro assay. Methods: Medical records of 25 patients with MDH, tested and confirmed at our allergy division, were retrospectively evaluated in terms of clinical course, involved drugs, daily drug dose, latency periods, test results of skin test and cellular assays, and tolerated drugs in subsequent pharmacological treatments. Results: Multiple drug hypersensitivity syndrome almost exclusively appeared as a delayed, often severe DHR and started in 14/25 with a drug reaction with eosinophilia and systemic symptoms (DRESS). Penicillins (13/25, 52.0%) and cephalosporins (6/25, 24.0%), typical high‐dose drugs, were most often identified as elicitors of MDH, especially at the first DHR, followed by aromatic antiepileptics (7/25, 28.0%), vancomycin (4/25, 16.0%), and antibiotic sulfonamides (4/25, 16.0%). Cephalosporins, clindamycin, and radio contrast media (RCM) were mainly involved in subsequent DHR. The median daily drug dose of all drug trigger was 1875.0 mg (662.5; 2100.0) at the first DHR and 600.0 mg (300.0; 1300.0) at subsequent DHR, P = .0420. Conclusion: High‐dose drugs, especially beta‐lactam antibiotics, RCM and clindamycin, are common elicitors of subsequent DHR in patients with MDH. Macrolides, quinolones, doxycycline, nonaromatic antiepileptics, andAbstract: Background: Multiple drug hypersensitivity syndrome (MDH) is used to describe persons with a drug hypersensitivity reaction (DHR) to at least two chemically unrelated drugs, confirmed by skin test or in vitro assay. Methods: Medical records of 25 patients with MDH, tested and confirmed at our allergy division, were retrospectively evaluated in terms of clinical course, involved drugs, daily drug dose, latency periods, test results of skin test and cellular assays, and tolerated drugs in subsequent pharmacological treatments. Results: Multiple drug hypersensitivity syndrome almost exclusively appeared as a delayed, often severe DHR and started in 14/25 with a drug reaction with eosinophilia and systemic symptoms (DRESS). Penicillins (13/25, 52.0%) and cephalosporins (6/25, 24.0%), typical high‐dose drugs, were most often identified as elicitors of MDH, especially at the first DHR, followed by aromatic antiepileptics (7/25, 28.0%), vancomycin (4/25, 16.0%), and antibiotic sulfonamides (4/25, 16.0%). Cephalosporins, clindamycin, and radio contrast media (RCM) were mainly involved in subsequent DHR. The median daily drug dose of all drug trigger was 1875.0 mg (662.5; 2100.0) at the first DHR and 600.0 mg (300.0; 1300.0) at subsequent DHR, P = .0420. Conclusion: High‐dose drugs, especially beta‐lactam antibiotics, RCM and clindamycin, are common elicitors of subsequent DHR in patients with MDH. Macrolides, quinolones, doxycycline, nonaromatic antiepileptics, and paracetamol were often tolerated. As the same drugs elicited both flare‐up reactions and real DHR, drug‐induced flare‐up reactions may be precursors of a possible second DHR and MDH. The administration of highly dosed drugs should be avoided in patients at risk for MDH. Abstract : The most common drug trigger in MDH are beta‐lactam antibiotics, AED, vancomycin, and sulfonamides. Cephalosporins, clindamycin, and RCM are often elicitors of subsequent DHR. Most drug trigger are highly dosed drugs. The daily drug dose in subsequent DHR is significantly lower than at the first DHR, indicating that MDH patients with subsequent DHR are able to react to lower drug doses. Abbreviations: AED, antiepileptic drugs; DHR, drug hypersensitivity reactions; MDH, multiple drug hypersensitivity; RCM, radio contrast media … (more)
- Is Part Of:
- Allergy. Volume 75:Issue 5(2020)
- Journal:
- Allergy
- Issue:
- Volume 75:Issue 5(2020)
- Issue Display:
- Volume 75, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 75
- Issue:
- 5
- Issue Sort Value:
- 2020-0075-0005-0000
- Page Start:
- 1178
- Page End:
- 1187
- Publication Date:
- 2020-01-01
- Subjects:
- drug reaction with eosinophilia and systemic symptoms (DRESS) -- drug hypersensitivity -- flare‐up reaction -- multiple drug hypersensitivity syndrome (MDH) -- T‐cell
Allergy -- Periodicals
616.97 - Journal URLs:
- http://estar.bl.uk/cgi-bin/sciserv.pl?collection=journals&journal=01054538 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1398-9995 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/all.14146 ↗
- Languages:
- English
- ISSNs:
- 0105-4538
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0790.945000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23899.xml